Sponsored by:

Molecular Imaging: Page 433

Hologic to buy Third Wave
By AuntMinnie.com staff writers
Women's imaging vendor Hologic has inked an agreement to purchase molecular diagnostic reagent developer Third Wave Technologies of Madison, WI, for approximately $580 million.
June 8, 2008
Avid launches phase II trial
By AuntMinnie.com staff writers
Avid Radiopharmaceuticals has begun a phase II clinical trial for its F-AV-45 molecular imaging compound for Alzheimer's disease.
June 8, 2008
IBA, Wilex ink licensing pact
By AuntMinnie.com staff writers
Belgian radiopharmaceutical firm Ion Beam Applications (IBA) has signed a licensing agreement for the worldwide marketing, distribution, and sales of Redectane from Wilex of Munich, Germany.
June 5, 2008
MDS to press AECL on Chalk River reactors
By AuntMinnie.com staff writers
The chief executive of Canadian healthcare company MDS wants the Canadian government and Atomic Energy of Canada (AECL) to reverse the decision to cancel the construction of two nuclear reactors dedicated to medical isotopes.
June 5, 2008
MDS rallies in Q2 results
By AuntMinnie.com staff writers
Despite the past year's reactor shutdown turmoil, Canadian healthcare company MDS and its radioisotope developer MDS Nordion of Kanata, Ontario, posted revenue increases for its second quarter 2008.
June 4, 2008
IsoRay authorizes stock repurchase plan
By AuntMinnie.com staff writers
Medical isotope developer IsoRay has authorized the repurchase of up to 1 million shares of the Richland, WA, company’s common stock.
June 2, 2008
ASCO news: PET studies advocated before head and neck, lung cancer surgeries
By Edward Susman
CHICAGO - Conducting an FDG-PET scan on patients with head and neck or lung cancer can help reduce unnecessary or futile surgical interventions, according to research presented this week at the 2008 American Society of Clinical Oncology (ASCO) meeting.
June 2, 2008
BSGI sensitive in detecting cancer, study says
By AuntMinnie.com staff writers
A study slated for the June issue of Radiology found that breast-specific gamma imaging is as sensitive as MRI for detecting the presence of most cancers and is more sensitive for ductal carcinoma in situ.
May 29, 2008
IBA finalizes acquisition of CIS bio
By AuntMinnie.com staff writers
Belgian radiopharmaceutical firm Ion Beam Applications (IBA) of Louvain-la-Neuve has moved to finalize its purchase of CIS bio International.
May 29, 2008
Using coronary CTA first versus SPECT cuts costs
By Eric Barnes
SPECT myocardial perfusion imaging has long been the primary modality for evaluating coronary artery disease. But research based on payor data covering millions of patients found that initial evaluation with coronary CT angiography cut costs significantly over a year's time for patients without coronary artery disease and the patient cohort overall.
May 29, 2008
2008 05 22 15 22 11 706
Draxis completes sale to Jubilant
By AuntMinnie.com staff writers
Draxis Health has finalized its acquisition by Jubilant Organosys of Noida, India.
May 28, 2008
ART appoints new chairman
By AuntMinnie.com staff writers
Medical device firm ART Advanced Research Technologies has tapped president and CEO Sébastien Gignac as its chairman.
May 27, 2008
Previous Page
Page 433 of 612
Next Page